|
CLP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.989380E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.744100E-03 |
| Normal-vs-Stage2 |
7.052800E-01 |
| Normal-vs-Stage3 |
7.245400E-01 |
| Normal-vs-Stage4 |
8.215800E-01 |
| Stage1-vs-Stage2 |
4.256300E-03 |
| Stage1-vs-Stage3 |
2.834700E-04 |
| Stage1-vs-Stage4 |
1.212350E-02 |
| Stage2-vs-Stage3 |
9.628000E-01 |
| Stage2-vs-Stage4 |
5.789000E-01 |
| Stage3-vs-Stage4 |
5.584800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.135400E-01 |
| Normal-vs-AfricanAmerican |
2.284800E-01 |
| Normal-vs-Asian |
2.877400E-01 |
| Caucasian-vs-AfricanAmerican |
7.354400E-01 |
| Caucasian-vs-Asian |
1.687830E-01 |
| AfricanAmerican-vs-Asian |
1.707580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.663200E-01 |
| Normal-vs-Female |
6.843800E-02 |
| Male-vs-Female |
1.741220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.824200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.054450E-01 |
| Normal-vs-Age(61-80Yrs) |
2.851600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.351200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.702000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.870000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.801400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.483800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.401000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.030200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.491700E-02 |
| Normal-vs-Grade 2 |
9.701900E-03 |
| Normal-vs-Grade 3 |
6.499600E-01 |
| Normal-vs-Grade 4 |
3.763200E-01 |
| Grade 1-vs-Grade 2 |
4.197000E-01 |
| Grade 1-vs-Grade 3 |
6.328100E-02 |
| Grade 1-vs-Grade 4 |
2.164400E-02 |
| Grade 2-vs-Grade 3 |
3.237200E-03 |
| Grade 2-vs-Grade 4 |
3.795600E-04 |
| Grade 3-vs-Grade 4 |
1.366170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.587000E-04 |
| Normal-vs-ccB subtype |
5.010800E-01 |
| ccA subtype-vs-ccB subtype |
8.20909999976749E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.745000E-01 |
| Normal-vs-N1 |
6.054400E-01 |
| N0-vs-N1 |
2.654400E-01 |
|
|
